4.8 Article

Luzp4 defines a new mRNA export pathway in cancer cells

期刊

NUCLEIC ACIDS RESEARCH
卷 43, 期 4, 页码 2353-2366

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkv070

关键词

-

资金

  1. Biotechnology and Biological Sciences Research Council (BBSRC), UK [BB/E025293/1]
  2. Wellcome Trust [083130/Z/07/Z]
  3. Royal College of Surgeons of England [RS123]
  4. Wellcome Trust Clinical Training Fellowship
  5. Royal College of Surgeons of England Research Fellowship
  6. Biotechnology and Biological Sciences Research Council UK
  7. Engineering and Physical Sciences Research Council UK
  8. BBSRC
  9. Wellcome Trust
  10. Biotechnology and Biological Sciences Research Council [BB/D011795/1, BB/J015067/1, BB/E025293/1] Funding Source: researchfish
  11. BBSRC [BB/J015067/1, BB/E025293/1, BB/D011795/1] Funding Source: UKRI

向作者/读者索取更多资源

Cancer testis antigens (CTAs) represented a poorly characterized group of proteins whose expression is normally restricted to testis but are frequently up-regulated in cancer cells. Here we show that one CTA, Luzp4, is an mRNA export adaptor. It associates with the TREX mRNA export complex subunit Uap56 and harbours a Uap56 binding motif, conserved in other mRNA export adaptors. Luzp4 binds the principal mRNA export receptor Nxf1, enhances its RNA binding activity and complements Alyref knockdown in vivo. Whilst Luzp4 is up-regulated in a range of tumours, it appears preferentially expressed in melanoma cells where it is required for growth.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据